禽腺病毒嵌合纤维蛋白(crecFib-4/11)疫苗同时保护鸡对抗肝炎-心包积液综合征(HHS)和包涵体肝炎(IBH)
本研究设计了一种结合FAdV-4和FAdV-11表位的重组嵌合纤维蛋白,并用无特定病原体鸡评估其同时预防HHS和IBH的效果。接种后分别用引起HHS或IBH的毒株攻毒,疫苗接种/攻毒鸡较各自攻毒对照组临床症状减轻、肝肿大受限、AST水平降低,并防止HHS相关淋巴器官萎缩,靶器官病毒载量显著降低。临床保护与攻毒前高抗体水平相关,但对FAdV-11中和抗体有限、对FAdV-4中和抗体缺失。
要点
- 嵌合纤维蛋白疫苗可同时减轻HHS和IBH攻毒后的临床症状与肝脏病变。
- 疫苗防止HHS相关胸腺和法氏囊萎缩,并显著降低靶器官病毒载量。
- 临床保护与攻毒前ELISA抗体水平高相关,但中和抗体反应有限或缺失。
核心结论
- 嵌合纤维疫苗概念可跨病毒种属边界扩展,是首个提供针对不同FAdV相关疾病全面保护的单组分FAdV亚单位疫苗。
研究设计与样本
- 研究用无特定病原体鸡接种新型重组嵌合纤维蛋白,随后分别用引起HHS或IBH的毒株攻毒,并设各自攻毒对照组。
主要发现
- 疫苗接种/攻毒鸡较各自攻毒对照组临床症状减轻、肝肿大受限、AST水平降低。
- 疫苗防止HHS影响的淋巴器官(如胸腺和法氏囊)萎缩,靶器官病毒载量显著降低。
- 临床保护与攻毒前用疫苗接种抗原包被的ELISA板测得的高水平抗体相关。
- 对FAdV-11的中和抗体产生有限,对FAdV-4的中和抗体缺失。
关键数值与推荐
- 原文未报告具体数值、比例、阈值、剂量、样本量、P值或置信区间。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the past decades, fowl adenovirus (FAdV)-related diseases became an increasing concern for the poultry industry worldwide. Various immunization strategies against FAdVs have been experimentally investigated, with a particular focus on subunit vaccines against hepatitis-hydropericardium syndrome (HHS), caused by FAdV serotype 4, and inclusion body hepatitis (IBH), caused by serotypes 2, 8a, 8b and 11. In this study, we extended our innovative concept of recombinant chimeric fiber proteins to design a novel chimera combining epitopes from two distinct serotypes, FAdV-4 and -11, and we investigated its efficacy to simultaneously protect chickens against HHS and IBH. Specific pathogen-free chickens were vaccinated with the novel recombinant chimeric fiber and subsequently challenged with either a HHS- or IBH-causing strain. Vaccinated/challenged birds exhibited a reduction of clinical signs, limited hepatomegaly and lower levels of AST compared to the respective challenge controls. Furthermore, the vaccine prevented atrophy of HHS-affected lymphoid organs, such as thymus and bursa of Fabricius, and viral load in the target organs was significantly reduced. Clinical protection was associated with high levels of pre-challenge antibodies measured on ELISA plates coated with the vaccination antigen. Interestingly, the development of neutralizing antibodies was limited against FAdV-11 and absent against FAdV-4, indicating that protection granted by such an antigen may be linked to different immunization pathways. In conclusion, we proved that the concept of chimeric fiber vaccines can be extended across viral species boundaries and represents the first single-component FAdV subunit vaccine providing comprehensive protection against different FAdV-associated diseases.
引用
- De Luca C, Schachner A, Heidl S, et al. Vaccination with a fowl adenovirus chimeric fiber protein (crecFib-4/11) simultaneously protects chickens against hepatitis-hydropericardium syndrome (HHS) and inclusion body hepatitis (IBH). Vaccine. 2022. PMID: 35151506. doi:10.1016/j.vaccine.2022.01.060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。